Update: EToro Shares Fall After Q2 Adjusted Net Income, Revenue Rise-February 2024-www.financetom.com

Update: EToro Shares Fall After Q2 Adjusted Net Income, Revenue Rise

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Update: EToro Shares Fall After Q2 Adjusted Net Income, Revenue Rise

Aug 12, 2025 7:41 AM

10:21 AM EDT, 08/12/2025 (MT Newswires) -- (Updates with the latest stock move in the first paragraph and headline.)

EToro ( ETOR ) shares were down nearly 6% in recent Tuesday trading after the company reported improved Q2 results.

The trading and investment platform reported Q2 adjusted net income of $0.56 per diluted share, up from $0.51 a year earlier.

Analysts polled by FactSet expected $0.50.

Revenue for the quarter ended June 30 was $2.09 billion, up from $1.85 billion a year earlier.

Analyst estimates weren't available for comparison.

Price: 52.07, Change: -3.24, Percent Change: -5.85

Previous page： Amerigo Resources Swings To Q2 Profit; Declared First Performance Dividend Next page： Clean Harbors' Q2 Earnings, Revenue Rise; Shares Gain Pre-Bell

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Amerigo Resources Swings To Q2 Profit; Declared First Performance Dividend

Jul 31, 2024

08:16 AM EDT, 07/31/2024 (MT Newswires) -- Amerigo Resources Ltd. ( ARREF ) on Wednesday swung to a profit for the second quarter on a significant strengthening of copper prices and firm cost management. It announced a net income of US$9.8 million for its second quarter compared to a loss of $3.8 million a year earlier. Amerigo's Q2-2024 financial results...

Clean Harbors' Q2 Earnings, Revenue Rise; Shares Gain Pre-Bell

Jul 31, 2024

08:16 AM EDT, 07/31/2024 (MT Newswires) -- Clean Harbors ( CLH ) reported Q2 earnings Wednesday of $2.46 per diluted share, up from $2.13 a year earlier. Analysts polled by Capital IQ expected $2.22. Revenue for the quarter ended June 30 was $1.55 billion, compared with $1.40 billion a year earlier. Analysts surveyed by Capital IQ expected $1.53 billion. Shares...

Teva Pharmaceutical Q2 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Revised

Jul 31, 2024

08:16 AM EDT, 07/31/2024 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) reported Q2 non-GAAP earnings Wednesday of $0.61 per diluted share, up from $0.56 a year earlier. Analysts polled by Capital IQ expected $0.55. Net revenue for the quarter ended June 30 was $4.16 billion, compared with $3.88 billion a year earlier. Analysts surveyed by Capital IQ expected...

Market Chatter: Meta Still Running Ads for Cocaine, Opioids on Facebook, Instagram

Jul 31, 2024

08:19 AM EDT, 07/31/2024 (MT Newswires) -- Meta Platforms ( META ) is continuing to run hundreds of ads on Facebook and Instagram that steer users to online marketplaces to buy illegal drugs, collecting revenue from a practice that violates its policy, The Wall Street Journal reported Wednesday. The tech giant was running ads marketing cocaine and prescription opioids as...